BETHESDA, Md., Oct. 09, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and …
Partnership to investigate Gain’s structurally targeted allosteric regulator candidates (STARs) in cellular models of Gaucher disease and Parkinson’s disease November 30, 2020 09:40 ET | …
GT-02287 Demonstrates Disease Modifying Capacity in Both GBA1 and Idiopathic Parkinson’s Disease Models GT-02287 Improves Mitochondrial Function and Provides Neuroprotective Effect in GBA1-Parkinson’s Disease Models …
Parkinson’s News Today October 3, 2024 https://parkinsonsnewstoday.com/news/parkinsons-therapy-increases-gcase-activity-phase-1-trial/
BETHESDA, Md., Oct. 03, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and …
GT-02287 Increases Peripheral GCase Activity GT-02287 Demonstrates CNS Exposure Company to Host Webinar to Discuss Results at 8:30 AM ET Today BETHESDA, Md., Sept. 30, …
Parkinson’s News Today October 3, 2024 https://parkinsonsnewstoday.com/news/parkinsons-therapy-increases-gcase-activity-phase-1-trial/
Parkinson’s News Today Sep 03 2024 https://parkinsonsnewstoday.com/news/gain-readies-phase-1b-trial-parkinsons-therapy-gt-02287/
BioWorld Aug 30 2024 https://www.bioworld.com/articles/712024-in-the-clinic-for-aug-30-2024?v=preview
Clinical Trials Arena August 30, 2024 https://www.clinicaltrialsarena.com/news/gain-therapeutics-parkinsons-trial/
Fierce Biotech Aug 29 2024 https://www.fiercebiotech.com/biotech/gain-hopes-prove-parkinsons-drugs-potential-next-year-after-phase-1-win
Neurology Live Aug 29 2024 https://www.neurologylive.com/view/gcase-targeting-parkinson-drug-gt-02287-target-engagement-encouraging-safety-early-stage-study
Gain Therapeutics recently participated in BTIG’s Virtual Biotechnology Conference 2024. We look forward to our continued collaboration and growing knowledge in the biotechnology industry. This …
Business and Corporate Update Call with interim-CEO Gene Mack Date: 8:30am ET, July 1, 2024 Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=EnkGqV2d
H.C. Wainwright Fireside Chat with Gene Mack – 5th Annual Neuro Perspectives Virtual Conference Date: June 27, 2024 Webcast: https://journey.ct.events/view/b9a0531d-bb19-4f33-8566-8e2002792bfb
Public Ventures Discovery Day with Eric Richman Date: March 19, 2024
Gain Therapeutics’ 2024 R&D update with KOL and Analyst Insight Date: Februrary 22, 2023 Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=ISgbES38
FORCE Family Office Webinar/Zacks Small Cap Research Webinar Date: December 5, 2023 Webcast: